LBP-046 A phase IIa basket clinical trial of allogeneic CD362-enriched umbilical cord-derived mesenchymal stromal cells (ORBCEL-CTM) in patients with primary sclerosing cholangitis and autoimmune hepatitis

Journal of Hepatology
June 1, 2024
Cited by 0

Abstract


Related Papers

No related papers found

Powered by citation graph analysis